MedTrace Logo

Simulation-Based Training Program Effect on Pediatric Nurses Regarding Heel-Prick Screening Test

NCT06685471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-11-12

No results posted yet for this study

Summary

This study aimed to assess the impact of simulation-based training on pediatric nurses' knowledge and performance regarding the heel-prick technique used during newborn blood screening tests in select hospitals in Saudi Arabia and Egypt. This study utilized an experimental pre-test and post-test design. The G\*Power Program® Version 3.1.9.4 was employed to determine the necessary sample size to fulfill the study's objectives. The sample consisted of 50 nurses recruited from the Maternity \& Children Hospital Bisha, Al-Namas General Hospital in the Kingdom of Saudi Arabia, and Pediatric Assiut University Hospital in Egypt. The current study's findings indicate that, following simulation-based training, pediatric nurses significantly improved their heel-prick knowledge and performance during the newborn blood screening test. This study provides strong evidence that the simulation-based training program improved nurses' knowledge and performance, and we advise all pediatric healthcare practitioners, physicians, and nurses employed in hospitals and healthcare facilities to undergo advanced simulation-based training. Nursing managers can target public hospitals with low scores by putting systematic methods into place to improve nurses' performance and knowledge in simulation-based training.

Conditions

  • Aspiration of Blood in Newborn

Interventions

DIAGNOSTIC_TEST

Screeing test

Simulation-Based Training Program Effect on Pediatric Nurses' Knowledge and Performance Regarding Heel-Prick during Newborn Blood Screening Test

Sponsors & Collaborators

  • Abeer Abd Elwahed Almowafy

    lead OTHER

Principal Investigators

  • Abeer Almowafy · Al-Azhar University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-07-30
Completion
2023-08-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06685471 on ClinicalTrials.gov